VTechWorks staff will be away for the Thanksgiving holiday beginning at noon on Wednesday, November 27, through Friday, November 29. We will resume normal operations on Monday, December 2. Thank you for your patience.

Browsing by Author "Foutz, Aaron"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Early preclinical detection of prions in the skin of prion-infected animals
    Wang, Zerui; Manca, Matteo; Foutz, Aaron; Camacho, Manuel V.; Raymond, Gregory J.; Race, Brent; Orru, Christina D.; Yuan, Jue; Shen, Pingping; Li, Baiya; Lang, Yue; Dang, Johnny; Adornato, Alise; Williams, Katie; Maurer, Nicholas R.; Gambetti, Pierluigi; Xu, Bin; Surewicz, Witold; Petersen, Robert B.; Dong, Xiaoping; Appleby, Brian S.; Caughey, Byron; Cui, Li; Kong, Qingzhong; Zou, Wen-Quan (2019-01-16)
    A definitive pre-mortem diagnosis of prion disease depends on brain biopsy for prion detection currently and no validated alternative preclinical diagnostic tests have been reported to date. To determine the feasibility of using skin for preclinical diagnosis, here we report ultrasensitive serial protein misfolding cyclic amplification (sPMCA) and real-time quaking-induced conversion (RT-QuIC) assays of skin samples from hamsters and humanized transgenic mice (Tg40h) at different time points after intracerebral inoculation with 263K and sCJDMM1 prions, respectively. sPMCA detects skin PrPSc as early as 2 weeks post inoculation (wpi) in hamsters and 4 wpi in Tg40h mice; RT-QuIC assay reveals earliest skin prion-seeding activity at 3 wpi in hamsters and 20 wpi in Tg40h mice. Unlike 263K-inoculated animals, mock-inoculated animals show detectable skin/brain PrPSc only after long cohabitation periods with scrapie-infected animals. Our study provides the proof-of-concept evidence that skin prions could be a biomarker for preclinical diagnosis of prion disease.